Amy Wesa

Galecto (Denmark) — Denmark

Immunology and Microbiology · Life Sciences

21h-index2.3kcitations101works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(36), CAR-T cell therapy research(24), Cancer Immunotherapy and Biomarkers(23), Immune Cell Function and Interaction(18), T-cell and B-cell Immunology(17)

Publications100 total

Figure 5 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 4 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 3 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 2 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 1 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
1557P IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) treatment of advanced solid tumors: Final results of a phase II basket trial
Annals of Oncology·2025
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient
International Journal of Molecular Sciences·2025Open Access
756 A phase 2 trial of the IO102-IO103 cancer vaccine plus pembrolizumab: results from the first-line (1L) cohort of PD-L1 high metastatic non-small cell lung cancer (NSCLC)
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Supplementary Figure from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Figure from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Figure 4 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2<sup>+</sup> Tumor Cell Recognition by Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 3 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2<sup>+</sup> Tumor Cell Recognition by Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 3 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
Supplementary Figure 1 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
Supplementary Figure 1 from Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2<sup>+</sup> Tumor Cell Recognition by Specific CD8<sup>+</sup> T Cells
2023Open Access
Data from Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Walter J. Storkus(27), Jennifer L. Taylor(9), Cecilia A. Vasquez(8), Maja Mandić(8), Angela D. Pardee(8), Simon C. Watkins(7), Anne Galy(6), Jennifer Taylor(6), James H. Finke(5), Leonard Μ. Neckers(5), Hideo Komita(5), Louis J. Sparvero(5), Andrew A. Amoscato(5), Sean Alber(5), Anthony Balducci(4), Brooke Helfer(4), Ronald M. Bukowski(4), Daniel Ciznadija(4), Ido Sloma(4), Mayumi Kawabe(4)